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ABSTRACT 
The comparison of two doses of intranasal midazolam in a paediatric 
dental emergency clinic 
A.E.O.M MAHGOUB 
Aim:  
The aim of the study was to compare two doses of intranasal midazolam (INM) 0.3 
mg/kg and 0.5 mg/kg in terms of effectiveness and recovery time. 
Design:-This study was a Randomized Controlled Trial (RCT) and Triple blinded 
study.  
Sample and methods A sample of one hundred and eighteen children aged from 4-6 
years old were randomly assigned for Intranasal sedation (INS) to either the 0.3 
mg/kg group or the 0.5 mg/kg group. Children were taken in fasting and non-fasting 
conditions. The children were monitored using a pulse-oximeter, the sedation was 
assessed using Wilson sedation scale and the anxiety and behaviour scales were rated 
by Venham’s scale throughout the treatment. The facial image Scale (FIS) was also 
used to assess anxiety and mood of children before and after treatment. 
Results 
The mean BMI of children was found to be from 14-16. Intranasal sedation with both 
0.3 mg/kg and 0.5 mg/kg midazolam was completed in 100% of the children. The 
pulse rates were within normal limit but statistically lower in the 0.5 mg/kg group. 
Oxygen saturation was above 98% in all except for one child who desaturated to 
90%. Thirty five percent found this route acceptable in this study; Nine percent had 
burning sensation from midazolam. The state anxiety between the two groups of 0.3 
mg/kg and 0.5 mg/kg were insignificant using Venham’s scale. However, behaviour 
scores showed statistical significant results of p value (0.03) and (0.04) in the 
behaviour during LA and behaviour during extractions respectively. The facial 
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images scale (FIS) ratings chosen by the children before and after sedation was 
insignificant to the anxiety and behaviour ratings.  
The FIS revealed that 66% chose a happy face at the end of treatment. Fifty percent 
of the children in the study chose the same image before and after sedation. There 
were no adverse events encountered during the procedure. 
Conclusion 
INS with midazolam using the 0.3 mg/kg or 0.5 mg/kg doses resulted in safe and 
effective sedation. The 0.5 mg/kg proved to be more effective than the 0.3 mg/kg in 
providing better behaviour and decreasing anxiety when compared with the 0.3 
mg/kg dose. The 0.5 mg/kg dose was found to be safe and the recovery time was 
slightly more than the 0.3 mg/kg but the difference was not clinically significant. 
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Background to the problem 
The paediatric emergency dental clinic at Tygerberg Oral Health Centre, in the 
Western Cape provides dental treatment for children who present with acute pain and 
sepsis and they are primarily managed with dental extractions. These children tend to 
be anxious and apprehensive and would therefore benefit from any form of sedation, 
as extractions tend to be an unpleasant procedure. The ideal sedation route provided 
to children for emergency extractions at Tygerberg Oral Health Centre is intravenous 
sedation (IVS). There is a scarcity of anaesthetists and medical practitioners trained in 
sedation, and therefore IVS is a limited treatment option in the South African public 
service. The large number of children that require this resource exacerbates the 
apparent lack of IVS resources. The implication is that the majority of children who 
receive extractions as emergency treatment do not have access to any form of 
sedation. Hence, the possibility that these children will become traumatised and not 
co-operate with any future dental treatment, is relatively high. This poor co-operation 
contributes to the possibility that they will subsequently require general anaesthesia 
for any future dental treatment, and this increases the burden on the general 
anaesthesia resources which is also limited and much more expensive than sedation. 
There is therefore a need for a solution that allows the operator to perform a sedation 
technique that is safe and effective without the mandatory presence of an anaesthetist/ 
or trained sedationist. 
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One of the greatest challenges facing dentists in paediatric emergency dental clinics is 
the management of anxious children who require emergency dental extractions. 
The delivery of safe and effective sedation along with anxiolysis (decrease of 
anxiety) is an important component under the umbrella of behaviour management in 
children. Anxious children in the pre-cooperative level are usually traumatised by 
conventional methods of dental extractions, leading to future anxiety and 
complicating subsequent dental visits that eventually lead to the need for treatment 
under dental general anaesthesia (DGA). 
Dental general anaesthesia (DGA) is preferred in cases where very anxious children 
need numerous extractions and extensive treatment. Despite the effective results 
morbidity is still a risk. It may also be associated with a few challenges; such as 
increased health care costs, time consumption, specialised equipment and specialist 
health professionals needed especially in an emergency facility setting.  
On the other hand, the safety margin of sedation may be a more practical and efficient 
option for the treatment of pre-cooperative children with mild to moderate anxiety in 
an emergency facility. Interestingly, a survey from an emergency dental clinic in the 
United Kingdom, found that 68% of the patients claimed nervousness and 43% cited 
fear and nervousness, as the reason for not seeking dental treatment. The authors 
concluded that offering dental sedation would be a viable option to improve care and 
alleviate fear (Ryding and Murphy, 2007).  
Intranasal sedation (INS) with midazolam has been recommended as a valuable 
adjunct to behaviour management to treat anxious children in an emergency setting 
(Johnson et al, 2010). INS has shown favourable outcomes in terms of the level of 
sedation and safety due to its faster and more acceptable route of administration 
(Johnson et al, 2010). 
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The American Academy of Pediatric Dentistry’s (AAPD) policy on early childhood 
caries (ECC) treatment also recommends sedation. To achieve safe and effective 
treatment, the policy by the AAPD states that a dentist must assess a child’s 
developmental level in addition to the extent of disease process to determine the need 
for pharmacological behaviour. As such, the dentist needs to choose between sedation 
and general anaesthesia (AAPD, 2011). 
2.1 Early Childhood Caries 
Early childhood caries (ECC) is defined as “at least one carious lesion affecting the 
maxillary anterior teeth in preschool-aged children”. It is also considered to be a 
virulent form of dental caries leading to widespread destruction of primary teeth 
(Gussy, 2006). 
In spite of the recent advances our current knowledge and understanding of dental 
caries, ECC still has an extremely high prevalence with one in three children in South 
Africa currently being affected (Postama, 2008). More than 80% of children in South 
Africa in the 4-5 years old  group with dental caries in are not treated (Van Wyk, 
2004).  
A course of action needs to be instituted by providing prevention programs and 
effective treatment plans (Van Wyk, 2004). The majority of children affected by ECC 
are at the pre-school stages and are also considered to be at the pre-cooperative level 
(Alwin et al, 1991). Unfortunately, children in this age group are most likely to 
exhibit dental fear and anxiety. This is considered as the main reason that leads to 
poor co-operation thus interfering in the development of rapport between child and 
dentist (Alwin et al, 1991). 
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The dilemma of limited and delayed treatment of ECC due to dental fear and anxiety 
motivated researchers to assess dental anxiety in children (Alwin et al, 1991). Dental 
fear was defined as “a dread of something specific” and anxiety is “the fear of the 
unknown”.  
The results of the study by Alwin et al (1991) to assess dental anxiety in children 
using Venham’s scale and the Children Manifest Anxiety Scale (CMAS) have shown 
no difference in general anxiety between anxious children and the control group. This 
study did however find significant differences between anxiety and cooperation 
ratings made by dentist and parents (Alwin et al, 1991). 
2.2 Anxiety 
Dental anxiety can persist into adulthood leading to the avoidance of dental care and 
subsequent deterioration of oral health. Therefore the assessment and management of 
child anxiety and implementation of new and different techniques is crucial (Gussy, 
2006).  
The measurement of anxiety does not use given equations to formulate the level of 
anxiety nor does it reveal what is masked behind it. They have been derived from 
theories such as the cognitive theory, which postulates that the central feature of 
anxiety disorder is the preoccupation with danger and responses to endangering 
situations. Asking how the children feel in a certain situation assesses the cognitive 
measure. This can be in form of a questionnaire or by using rating scales (Alwin et al, 
1991). 
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In the assessment of dental anxiety in children, it has been stated that researchers 
favoured the assessment of state and trait anxiety (Alwin et al, 1991). “Trait anxiety” 
is a relatively stable level of anxiety proneness that varies between individuals and 
state anxiety is a transitory feeling of anxiety experienced in specific situations” 
(Alwin et al, 1991). Both these terms are measured by the State-trait anxiety 
inventory (STAI)” (Alwin et al, 1991). 
Facial image scale (FIS) is another instrument that was proven in its validity when 
compared to the Venham picture test. The FIS has been favoured in satisfying most 
of the criteria’s needed to determine anxiety in young children.  
FIS was chosen for the reasons of its validity, easy to understand for young children 
and practical in the dental setting (Buchanin and Niven, 2002).  
2.3 Temperament  
Temperament is another factor that is found to be associated with dental fear and is 
defined as “an emotional quality, which varies individually but is relatively stable 
over time” (Anrup, 2002). Temperament does contribute to the behaviour of children, 
but unpleasant dental experiences probably contribute more to the development of 
dental fear (Anrup, 2002).  
In a study sample in Sweden of 124 children; shyness and abnormal feelings scored 
higher among children with dental fear in contrast to those without such fear (Anrup, 
2002). The low socio-economic status also does weigh on the orientation to dentistry 
and leads to dental fear increasing exponentially (Anrup, 2002).  
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2.4 Intervention Options 
The Non-Pharmacological Approach 
Non-pharmacological behaviour management is a comprehensive methodology, 
meant to build a relationship between the patient and the dental professional, which is 
considered essential to achieve a positive dental attitude and experience (Anrup, 
2002). Some of the techniques of behaviour management are the “tell, show, do,” 
method, modelling and desensitisation (Anrup, 2002). The application of these non-
pharmacological behaviour management techniques to manage an anxious child can 
be very time consuming and frequently extensive dental caries in young children 
necessitates treatment under dental general anaesthesia (Anrup, 2002). 
The pharmacological approach is by means of: 
1. Dental general anaesthesia (DGA) is a drug-induced loss of consciousness. The 
ability to maintain independent respiratory function is impaired (SAJA, 2010). 
Patients require assistance in maintaining a patent airway, and positive pressure 
ventilation may be required because of depressed spontaneous ventilation or drug-
induced depression of neuromuscular function. The cardiovascular function may also 
be impaired (SAJA, 2010).  
Dental general anaesthesia can be used for patients who fit the physical status 
classification but are associated with a risk of mortality thus considered an invasive 
option, when compared to the non-pharmacological approach or sedation. Recent 
clinical guidelines from the British Society of Paediatric Dentistry state that the use 
of DGA is indicated when non-pharmacological techniques is not adequate to manage 
the child in the dental chair. 
 
 
	  	  
	  
9	  
2. Conscious sedation is a medically controlled state of depressed consciousness that 
allows protective reflexes to be maintained in cardiovascular stability, patent airway 
and permits appropriate response by the patient to physical stimulation or verbal 
command (Krauss and Green, 2000; Nikhil, 2009). 
Conscious sedation is indicated in a child that has mild to moderate anxiety and 
willing to cooperate with treatment. Other indications are children who suffer from 
movement disability and lack psychological and emotional maturity to enable an 
unpleasant and complicated procedure to be carried out without distress to the patient 
(Nikhil, 2009). 
The goals of conscious sedation are as follows: - (SAJAA, 2010) 
1. To provide the most comfortable, efficient and high quality dental service.  
2. To control inappropriate behaviour. 
3. To produce a positive dental attitude. 
4. To allow for safe and quick recovery of patients. 
Conscious sedation is the technique that “utilizes drugs to induce a cooperative state 
in an anxious child” (SAJAA, 2010). Paediatric dentists should be aware that sedation 
represents a continuum and should consider guidelines of the use of sedative agents 
and carrying out the treatment (SAJAA, 2010). 
Charles J Cole stated in the guidelines for the safe use of procedural sedation and 
analgesia for diagnostic and therapeutic procedures in children that safe sedation of 
children requires a protective net composed of skilled personal and reliable 
monitoring equipment (SAJAA, 2010). The appropriate selection of patients, drugs 
usage, age and size plus appropriate airway management equipment and drugs to 
sustain life is also important. Seizures, respiratory arrests and death in a variety of 
practice settings have occurred when any of these are deficient” (SAJAA, 2010). 
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The classification of patient selection guidelines set by the South African Journal 
of Anaesthesia and Anaesthesiology and the AAPD regarding patient’s physical 
health status for Sedation: 
 Table 1 adapted from SAJAA (2010) 
The types of conscious sedation used in dentistry are classified according to the route 
of administration i.e. oral, inhalation, intravenous and intranasal sedation. 
Oral Sedation 
When taken orally a sedative drug such as midazolam is rapidly absorbed in the 
gastrointestinal tract and reaches its peak effects in about 30 minutes; with a half-life 
of about 1.75 hours. It has been proven to be very effective in doses between 0.5 to 
0.75 mg/kg (Al-zahrani et al, 2009).   
Oral sedation is usually the most popular route of sedation due to the following 
advantages, firstly it is a non-invasive procedure as children fear injections, secondly, 
there is no mask involved as in the inhalation route where children become very 
uncooperative and thirdly, it has good patient acceptability (Lee-kim et al, 2004).  
The disadvantages would be the long onset duration and dose determination. The risk 
is over sedation and need for intravenous cannulation for administration of reversal 
antagonist drug (flumazenil) (Adamji et al, 2011).  
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Inhalation Sedation 
Inhalation sedation with nitrous oxide and oxygen is also a popular technique for 
paediatric dental sedation. It involves the titration of nitrous oxide and oxygen using a 
machine, which delivers the gas mixture to the patient via a nasal hood. The titration 
of nitrous oxide is critical, and therefore the nitrous oxide concentration should range 
from 20-40% (Adamji et al, 2011). 
Inhalation sedation is contraindicated in patients with moderate/severe learning 
disability due to the inability to tolerate the nasal mask and cooperate with nasal 
breathing, and patients’ with chronic obstructive pulmonary disease (Adamji et al, 
2011). 
Intravenous Sedation  
Intravenous sedation (IV) using combination of drugs is less predictable in young 
children and may lead to longer recovery periods because of over sedation (Mikhael 
et al, 2007).  
Collado (2013) conducted a clinical trial comparing the efficacy and tolerance of 
midazolam administration between patients with intellectual disabilities and patients 
with dental anxiety. It was concluded that intravenous administration of midazolam is 
an effective and well-tolerated procedure. 
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Intranasal Sedation (INS) 
Nowadays as mentioned in the study, INS with midazolam is also being developed 
and provided in emergency boxes for the treatment of status epileptics in a form of a 
spray nozzle and nasal adapter (Gilchrist et al, 2007). 
Intranasal sedation (INS) is considered to be an easy and painless route of 
administration probably due to better compliance in children (Mazaheri et al, 2007).  
This is highlighted when compared to challenges faced with placement of cannulas 
for IV sedation and appropriate mask positioning for inhalation sedation (Mazaheri et 
al, 2007).  
The use of intranasal sedation (INS) according to SAJAA (2010) guidelines is not 
recommended due to the burning sensation and bitter taste experienced by the 
children during INS administration. However, the use of INS enables rapid onset 
sedation and provides the shortest recovery period than any other route. This is 
essential in an emergency setting for dental extractions. This could be a viable route 
of sedation for emergency dental extractions if the burning sensation and bitter taste 
can be resolved or managed. Furthermore, the need for sedation is on the increase and 
there is a scarcity of anaesthetists to work in the public health service. Sedation can 
be administered through the different routes other than the IV route which is 
considered “advanced” sedation and is restricted to skilled sedationists (Roelofse, 
2011). Therefore, it was suggested that operator-sedationists such as dentists and 
healthcare professionals can administer single drugs for sedation via all other routes 
except IV (Roelofse, 2011) providing they have the appropriate training in basic life 
support (BLS) and paediatric advanced life support (PALS) (Chiang, 2011). This 
ensures minimal sedation which renders a wide margin of safety (SAJAA, 2010), and 
hence to deliver optimal treatment to the large number of anxious children in a 
paediatric emergency dental setting.   
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Also, intranasal midazolam is gaining popularity as a conscious sedation technique in 
the management of patients who cannot cooperate with cannulation (Adamji et al, 
2011). It is delivered via a Mucosal Atomising Device (MAD) and is rapidly 
absorbed through the nasal mucosa into the systemic circulation (Adamji et al, 2011). 
The intranasal route has the potential advantage of rapid absorption, bypassing the 
first portal pass metabolism therefore a much faster onset than the other routes 
administered (Lee-Kim et al, 2004). It is also three times faster than the oral route and 
risk of child spitting the medication is highly unlikely in this route (Lee-Kim et al, 
2004). The intranasal (IN) sedation route is also used by 75% of anaesthetists in the 
United States as a premedication prior to general anaesthesia (Mazaheri et al, 2007). 
It therefore deserves to be considered as a possible option provided the burning 
sensation and bitter taste can be eliminated. 
Oral sedation and inhalation sedation are the most commonly used in dentistry due to 
fear of injection in children. However, the oral route has the disadvantage of a long 
onset time and the compliance needed by parents to starve the child prior to the 
procedure.  
Midazolam is the drug of preference in dentistry due to its remarkable advantages 
when compared to diazepam and other drugs. It is a benzodiazepine that has high 
water solubility resulting in less pain experienced during administration (Wildschut et 
al,  2011). The amnesic effect of midazolam is better than diazepam and its efficacy 
and safety have been extensively studied in both adults and children (Wildschut et al,  
2011). 
Midazolam is also effective for sedation as a single drug or in combination with an 
opioid. Adequate sedation for procedures in the emergency room is achieved in over 
90% of all procedures when midazolam is used as a single drug. Moreover, it is both 
cost effective and has high safety profile when administered appropriately with 
adequate monitoring and experienced personnel (Wildschut et al, 2011). 
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The behavioural outcome was the focus of a systematic review conducted to evaluate 
the efficacy of midazolam as a premedication. A total of 30 out of 171 randomized 
controlled trials (midazolam vs. placebo) were identified. The authors concluded that 
“premedication with midazolam 0.5 mg/kg administered 20–30 min preoperatively, is 
effective in reducing both separation and induction anxiety in children (grade A 
recommendation), with minimal effect on recovery times” (Wildschut et al, 2011). 
A study by Lee-Kim and colleagues compared between intranasal and oral sedation in 
both groups to assess time of onset and maximum working time, efficacy and safety 
for patient requiring treatment. (Lee-Kim et al, 2004).                                                                 
The study concluded that intranasal sedation using midazolam as the active drug was 
three times faster than the oral administration of midazolam. Although, the overall 
behaviour of patients was similar in both groups, more movement and                                                       
less sleep were seen with the IN group at the end of the treatment (Lee-Kim et al, 
2004).      
Another study to assess the use of intranasal midazolam by Gilchrist et al (2007) was 
conducted for the purpose of doing dental extractions or simple surgical procedures 
for a sample of twenty children aged between 2-9 years of age. They were given a 
dose of 0.25 mg/kg with successful results including high oxygen saturations pre and 
post operatively. All patients were alert and awake and responsive throughout the 
treatment (Gilchrist et al, 2007). The mean time for the onset of the treatment was 
calculated to be 13 min. (treatment duration ranged from 5 to 20 min with the average 
of 17 min). Patients were discharged after a mean average of 46 min (Gilchrist et al, 
2007).  
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Chiaretti et al (2011) evaluated the effectiveness of IN midazolam and noted high 
levels of satisfaction by doctors and parents in this study. Positive remarks were made 
due to its ease of administration in addition to its desired level of sedation and quick 
recovery. Lidocaine spray was added in a concentration of 0.5 mg/kg via mucosal 
atomiser device to avoid any nasal discomfort or burning sensation caused by the 
intranasal midazolam. 
It concluded that the presence of inhalation sedation and intravenous sedation is a 
useful adjunct to treatment but needs to have the required skills, competency and 
proper setting for safe and useful application (Woolley et al, 2009). 
The combination of inhalation sedation (nitrous oxide) with 0.6 mg/kg oral 
midazolam in comparison to oral midazolam only, has shown similar results. It was 
concluded that the combination of inhalation sedation and oral midazolam produced 
less movement and more comfort was to both the children and operators (Al-Zahrani 
et al, 2009). 
In a double blind random control trial Rakaf et al (2001) assessed the effectiveness of 
intranasal midazolam in three different concentrations; group A (0.3 mg/kg), B (0.4 
mg/kg) and C (0.5 mg/kg). The results showed a longer duration of action (60 min) in 
group C whereas group A and B ranged between (25-40 min).  
The results achieved were 79%, 96%, 100% effectiveness of sedation to groups A, B 
and C respectively. The dosage of 0.5 mg/kg was shown to be the most effective and 
safe in prolonging duration of sedation to complete the desired treatment (Rakaf et al, 
2001).  
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All doses administered showed statistically significant results regarding the general 
behaviour of child to accept treatment (P<0.05) (Rakaf et al, 2001). The study has 
also shown an important finding that further favours this route since there was no 
difference in terms of fasting or non-fasting child where child is obliged to starve 
before dental session for 4-6hrs (Rakaf et al, 2001).  
The acceptability of the oral route in children is higher when compared with the other 
routes due to fear of injection (Lee-Kim et al, 2004). However, the intranasal route 
could still be of greater use in an emergency setting due to its faster onset and shorter 
duration of action (Lee-Kim et al, 2004).  
2.5 Conclusion 
The effective delivery of sedation and analgesia reduces children’s fear in a 
threatening environment and reduces their anxiety from an unpleasant procedure such 
as dental extraction. According to the literature, the administration of intranasal 
midazolam with doses of 0.3 mg/kg, 0.4 mg/kg and 0.5 mg/kg produced favorable 
results in terms of effectiveness, safety margin and recovery and would be beneficial 
in an emergency clinic, were time is of essence (Rakaf et al, 2001; Chiaretti et al, 
2011; Gilchrist et al, 2007; Lee-Kim et al, 2004; Wildchut et al, 2011).  
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3.1 Aim of the Study 
The aim of the study was to compare two doses of intranasal midazolam (INM) 0.3 
mg/kg and 0.5 mg/kg in terms of safety, effectiveness and recovery time. 
3.2  Objectives  
The objectives of the study was to:- 
(A) Assess the effectiveness of 0.3 mg/kg INM and 0.5 mg/kg INM in a paediatric 
emergency dental clinic.  
(B) Compare the recovery time of 0.3 mg/kg INM and 0.5 mg/kg INM. 
(C) To show that INM can be safely used to treat anxiety in children. 
3.3  Study Design     
This study was a Randomized Controlled Trial (RCT), Triple blinded study:  
1. Operator one, 2. Operator two, 3.Two Raters 
• Operator 1 was the nurse who administered the intranasal sedation.  
• Operator 2 was the dentist who performed the dental procedure.  
• Two dentists were the raters who assessed the anxiety of the children by using 
the Venham’s anxiety scale, Facial image scale and Wilson scale for sedation. 
 
3.4  Methodology 
Pilot Study 
A pilot study was conducted with 10 patients in order to evaluate:- 
• The feasibility of the study 
• Any adverse events 
• The statistical variability in order to predict an appropriate sample size 
• The study design 
• The inter-rater reliability 
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3.5 Sample Size  
A sample of one hundred and eighteen physical status classification (ASA) class I 
children aged from 3-6 years old were included from the patients that attended the 
paediatric dentistry emergency clinic at the Tygerberg Oral Health Centre, University 
of Western Cape, South Africa. 
All the patients attending who met the inclusion criteria were included in the study. 
The patients were randomly assigned into two equal groups:- 
1. Group A was administered 0.5 mg/kg intranasal midazolam (INM)   
2. Group B was administered 0.3 mg/kg INM. 
The randomisation process was conducted by placing an equal number of papers 
with A or B written on them. These pieces of paper were folded and then placed 
in a box where patients chose one folded piece of paper that they handed to the 
nurse who recorded the doses to be given. 
The Inclusion Criteria 
1. Children aged from 3-6years old. 
2. Patients who were medically fit (ASA I) with no sign and symptoms of any 
systemic disease or with a well-controlled systemic disease.  
3. Children who attended the dental clinic only for emergency extractions of 
primary teeth. 
4. Children who were mild to moderately anxious. 
5. Children with not more than four extractions. 
6. Children with no airway abnormalities or known syndromes. 
7. Children who were not allergic to midazolam.  
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The Exclusion Criteria  
1. Age less than four years or more than six years of age. 
2. Children that need more than four teeth for extraction. 
3. Pulmonary, cardiovascular, gastrointestinal or neurological problems, or 
significant anaemia. 
4. Children with congenital syndromes or major congenital anomalies. 
5. Obesity (> 95th percentile body mass index (BMI) for age). 
6. Children who had nasal polyps or nasal congestion. 
7. Children with any adverse drug allergies. 
3.6 Data Analysis  
The data was collected from the record sheets and then entered into Microsoft 
EXCEL. 
The data was then analysed with the R program to compare the efficacy and average 
recovery time between the two groups. 
3.7 Drug and Dosage  
• First, 5 mg/ml lignocaine of 0.2 mg/kg concentration was squirted into each 
nostril with an insulin syringe using the MAD device.  
• The lignocaine was allowed to penetrate the mucosa for 3-4 min to allow for 
the nasal mucosa to become anaesthetised. 
• The MAD device was also used to spray equal amounts of the chosen dose of 
midazolam into each nostril. 
 
 
 
 
	  	  
	  
21	  
3.8 Ethical Consideration 
The literature has stated that midazolam is an effective drug for sedation as a single 
drug or in combination with an opioid. As a single drug, adequate sedation for 
procedures in the emergency room is achieved in over 90% of all procedures. 
Midazolam has been shown to be safe with no serious side effects reported and is cost 
effective (Wildschut et al, 2011; Gilchrist et al, 2007; Rakaf et al, 2001; SASA, 
2010).  
Permission was requested from the:- 
• Clinical Dean at the Faculty of Dentistry at the Tygerberg Oral Health Centre 
to conduct the study in the paediatric emergency dental clinic. (Appendix J). 
• Faculty Research Committee of the University of the Western Cape. 
• Research Senate Committee of the University of the Western Cape. 
Parents were given written information sheets (Appendix D) so that they understood 
the nature of this study. Prior to the appointment a written consent was obtained after 
the child was assessed for the procedure requirements. Patients were encouraged to 
ask questions, if anything was not clear. Parents were also informed that data to be 
collected would be treated as strictly confidential, and no individually identifiable 
information would be published. Parents were also given the free will and right to 
decline the procedure at any time and admit their child for emergency extraction 
without sedation. 
3.9 Conflict of Interest 
The researcher declared no interest with manufacturers and suppliers, and had no 
intentions of advertising and had no conflict of interest, with a specific party or 
organisation. 
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Statistical Analysis  
The T-test, Chi Square and the Fisher exact test were used to compare mean values 
between variables of groups 0.3 mg/kg (group A) and 0.5 mg/kg (group B) using the 
R software and illustrated by tables, graphs and charts. 
Results 
The inter-rater reliability between the two raters revealed the proportion of agreement 
to be 70%. The gender in relation to anxiety and behaviour proved not to be 
statistically significant.  
The correlation of age with the facial image chosen before treatment was not 
statistically significant (p=0.777).  
Body mass index (BMI) of children in both dose groups 
The majority of the children presented with a BMI value of 14-16 (figure 1). There 
was no statistical significance in the BMI value between the 0.3 mg/kg (A group) and 
0.5 mg/kg (B group) (p=0.131) (figure 1).  
Figure 1  The BMI of children  
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The number of extractions in relation to the 0.3 and 0.5 group 
The number of extractions in relation to groups A and B groups was not statistically 
significant as most of the p-values were greater than 0.05. The few cases where the 
Chi-squared p-value was less than or equal to 0.05, the Fisher exact test was used.  
Pulse Rate (PR) 
The baseline pulse rate (PR) revealed mean values of 103.5 in group A (0.3 mg/kg) 
and 100.3 in group B (0.5 mg/kg). The baseline PR in the 0.3 mg/kg and 0.5 mg/kg 
group was not statistically significant (p=0.2).  
The final PR revealed mean values of 115 in group A and 108 in group B with p = 
0.029 making the final PR statistically significant  (figure 2). 
Figure 2:- The pulse rate of both dose groups 
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Oxygen saturations 
The mean oxygen saturations at baseline were statistically significant (p=0.004) with 
a value of 99.33 in group A (0.3 mg/kg) and 98.627 in group B (Figure 3).  
The final oxygen saturation yielded mean values of 98.53 in group A and 98.69 in 
group B with a p value of 0.5 making the final oxygen saturation rate statistically 
insignificant. Only one child had a lower oxygen saturation of 90% in the recovery 
stage, which was clinically significant (Figure 3). 
Figure 3:- Oxygen Saturations of both dose groups 
 
 
Sedation Effectiveness  
The Wilson sedation scale which measures the effectiveness of sedation, revealed 
100% effectiveness in both groups A and B. The majority of children (97%) 
displayed a sedation scale rating of two (patient drowsy) and only four children (3%) 
displayed a sedation scale rating of three (patients eyes closed but rousable to 
command).   
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Table 2 Venham Anxiety scale 
Scales 
 
Anxiety 
Scale 0  
 
Relaxed and smiling 
Scale 1 
 
 
Uneasy and concerned 
  Scale 2 Scared 
  Scale 3 Crying 
  Scale 4 General crying not related to treatment 
  Scale 5 Out of proportion to threat 
  
INS Acceptability  
Figure 4:- The anxiety of the children during Intranasal (IN) administration 
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Table 3:- Venham behaviour Scale 
Scales 
 
Behaviour 
Scale 0  
 
Total cooperation 
Scale 1 
 
 
Mild, soft verbal protest or (quiet) 
crying 
  Scale 2 Protest more prominent. Both crying 
and hand signals. 
  Scale 3 Protest presents real problem to dentist 
  Scale 4 Protest disrupts procedure 
  Scale 5 General protest, no compliance or 
cooperation 
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 Table 4:- The Anxiety scores at all stages of treatment of groups A 
and B 
  Table 4 provides a detailed indication of the anxiety displayed by the children at 
the different stages of treatment. 
Scales (0 scales)  (1 scales) (2 scales) (3 scales) (4scales) (5scales) 
Before INS 86 %  9 % 5 %  0 % 0 % 0 % 
During INS 35 % 24 % 31 % 8 % 2 % 0 % 
Before LA 85 % 8 % 7 % 0 % 0 % 0 % 
During LA 23 % 15  % 55 % 4 % 3 % 0 % 
Before 
Extraction 
81 % 9 % 8 % 2 % 0 % 0 % 
During 
Extraction 
35 % 20 % 31 % 12 %  2 % 0 % 
 
The anxiety scales in relation to dose 
The anxiety scales did not show any statistical significance during all the stages of 
treatment between groups A and B (p>0.05) (Figures 5-10). 
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The different anxiety scales during stages of treatment 
 
Figure 5:- Anxiety before IN sedation (INS) 
 
 
Figure 6:- Anxiety scale scores during INS  
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Figure 7:- Anxiety scale scores before local anaesthesia (LA) 
       
 
 Figure 8:- Anxiety scale scores before extractions/s 
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The behaviour scales during LA and extraction  
The behaviour between the two doses showed statistical significance only in the 
behaviour of Local Anaesthesia (LA) t-test, p-value (0.04), and the extraction using 
the t-test, the p-value was 0.03. Therefore, the higher dose of 0.5 mg/kg had lower 
behaviour scales than the 0.3 mg/kg dose on both the LA and extraction stages. (See 
figure 9 and 10) 
 
Figure 9:- Behaviour scale scores during local Anaesthesia 
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Figure 10:- Behaviour scale scores during extraction/s 
 
Nine % (n=5) of the sample in group A displayed anxiety and behaviour scores of 
zero during all the stages of treatment in comparison to 22% (n=13) zero scores in 
group B.  
Facial image Scale (FIS): 
The association between the facial image test scores (FIS) in groups A and B chosen 
before INS administration was not statistically significant (p-value = 0.4659) (Figure 
11). 
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Figure 11:- FIS before INS 
 
 
However, the association between the facial image test scores in groups A and B 
chosen after INS administration was statistically significant (marginal p value 
=0.059) (Figure 12). 
Figure 12:- FIS after treatment 
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Figure 13:- Mood of children (FIT) before and after treatment 
  
 
Figure 14:- Overall mood (FIT) 
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Facial image Scale (FIS) rating before and after sedation (Appendix G) 
 
Table 8:- FIS before sedation in the 0.3mg/kg group 
Happy Scale 1 = 41.32% J  
Scale 2= 22.41% J 
Neutral Scale 3= 22.41% 
Sad Scale 4= 3.44% L  
Scale 5= 10.34% L 
 
Table 9:- FIS after sedation in the 0.3 mg/kg group. 
Happy J Scale 1 = 36.2% J  
Scale 2= 18.9% J 
Neutral Scale 3= 22.4% 
Sad L Scale 4= 3.44% L  
Scale 5= 18.9% L 
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Table:-10 FIS before sedation in the 0.5 mg/kg group. 
Happy Scale 1 = 41.6% J  
Scale 2= 26.6% J 
Neutral Scale 3= 13.3 % 
Sad Scale 4= 10% L  
Scale 5= 8.3% L 
 
Table:-11 FIS after sedation in the 0.5 mg/kg group. 
Happy Scale 1 = 38.3% J  
Scale 2= 28.3% J 
Neutral Scale 3= 16.6%  
Sad Scale 4= 11.6% L  
Scale 5= 5% L 
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Time of procedure   
The time of the procedure from time of INS administration to extraction were mean 
values of 35.21 min in 0.3 mg/kg and 36.45 min in the 0.5 mg/kg group, p-value 
(0.34) hence statistically not significant.  
Figure 15:- Time of procedure 
 
 
In group A the discharge time recorded from extraction to discharge time was 16.5 
minutes and in group B the discharge time was 18.8 minutes. This shows a statistical 
significance (Figure 16). The analysis using the Welch t-test gave P=0.044, but the 
Wilcoxon rank sum test gives P=0.098 suggesting small statistical significance 
between the two means.  
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Figure 16:- Discharge Times of group A and B 
  
The discharge score of 12 at 15 min between the two groups was analysed by the Chi-
square and Fisher exact test. This showed p-value= 0.04318 and Fisher exact value of 
0.034. The proportion of discharge score=12 is greater in the 0.3 mg/kg group, hence 
statistically significant.  
The percentages of the score of 11 or less indicating more than 15 minutes for 
recovery is 6.2% in the 0.3 mg/kg group and 21% in the 0.5 mg/kg group.  
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Side Effects  
Figure 17:- Side effects due to INS  
The side effects experienced by patients due to the INS are illustrated by figure 17. 
 
 
  
 
 
 
  
 
The three percent illustrated by “other” represents the one child who experienced a 
dull aching pain in the head for a few minutes and the child who presented with 
hiccups for a few seconds (See figure 17). 
 
 
 
 
 
 
42%	  
9%	  
30%	  
12%	  
4%	   3%	  
Side	  Effects	   None	  	  burning	  sensation	  swallowed	  the	  drug	  	  sneezing	  coughing	  others	  
	  	  
	  
40	  
 
 
 
 
  
Chapter (5) 
                      Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
	  
41	  
Discussion 
 
The intranasal route for sedation was selected for this study due to its rapid onset, 
greater bioavailability and quick recovery, thus making it more appropriate for use in 
an emergency setting for children in the pre-cooperative stage (Lee Kim et al, 2004). 
The only drawback of the administration of intranasal sedation is that a burning 
sensation of the nasal mucosa has been reported in children (Lee Kim et al, 2004). 
Chiareitti et al (2011) conducted a study using INS with midazolam but administered 
a local anaesthetic (LA) spray (Lignocaine) in order to anaesthetize the nasal mucosa 
prior to intranasal sedation (INS) and they reported that there was no burning 
sensation experienced in 100% of their sample.  This motivated the researchers in this 
study to include a local anaesthetic (LA) (Lignocaine) in order to anaesthetize the 
nasal mucosa prior to intranasal sedation (INS) and thus avoid the unpleasant burning 
sensation experienced. The effectiveness can be acknowleged from the results in this 
study as discussed later. 
The drug (midazolam) utilized in the INS route was selected because it provides an 
appropriate degree of memory loss (Gilchrist et al, 2007). The unpleasant experience 
of the dental extractions is therefore forgotten by the child and future dental treatment 
can be positive thus allowing the child to achieve an improved oral health status 
(Alzahrani et al, 2009). Amnesia is strongly recommended in young children 
undergoing unpleasant procedures such as dental extractions (Gilchrist et al, 2007) as 
it was shown that most of the extremely anxious children in their first dental 
appointment experience psychological trauma and the parents rated the dentist as 
unfriendly (Salem et al, 2011).  
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A literature search by the researcher using several search engines such as PubMed did 
not identify any randomized clinical trials conducted comparing different doses of IN 
midazolam in an emergency setting thus far. Hence, two doses were assessed in terms 
of safety, effectiveness and recovery times of each dose in order to determine the 
dose that would be most appropriate for an emergency setting where time and 
recovery area space is of the essence.                                                                           .   
Previous literature proved that doses of the 0.3 mg/kg and 0.5 mg/kg midazolam 
resulted in successful sedation (Rakaf et al, 2001). However these studies did not 
compare the doses in a paediatric dental emergency clinic. This study therefore 
aimed, to compare doses of intranasal midazolam that would be of significant benefit 
in a paediatric dental emergency clinic. 
The results of this study revealed a 100% success rate of INS with both doses of 0.3 
mg/kg and 0.5 mg/kg midazolam in children by attaining a safe and effective    
procedure. The safety was assured by continuously monitoring the oxygen saturations 
of the children. On the other hand, the specialists rated effectiveness of sedation in its 
capability to decrease anxiety and motion of children to allow dental extractions to be 
performed successfully.                                               .                                                    
Gender, age and BMI were included in this study to observe if any of these 
parameters revealed a statistical difference to the anxiety and behaviour ratings of 
each of the dose groups. Seeing that children at the pre-cooperative level lack the 
cognitive ability to understand the necessity of the procedure, the unknown frightens 
them (Buchanin and Niven, 2002). These parameters were not included in previous 
studies (Rakaf et al, 2001; Wood, 2011; Lee-Kim et al, 2004) in relation to the 0.3 
mg/kg and 0.5 mg/kg doses, and therefore were analysed to assess if any of the   
variables are significant for future considerations to dose administration.                      
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There was no difference in the anxiety levels between males and females. These 
results are in line with similar studies conducted by Buchanin and Niven (2002). The 
different ages of children were not related to their anxiety and behaviour ratings. The 
correlation of the facial image scale and age before treatment showed that age was 
not linked to the mood of the child or state of anxiety. There was also no significant 
difference between the two dose groups in correlation to BMI. 
The mean BMI of both groups was from 14-16 and did not influence on the 
effectiveness of both 0.3 and 0.5 mg/kg doses (P=0.131). The anxiety and behaviour 
scores of the children in this study were not influenced by either gender, age or BMI. 
Hence, gender, age and BMI were not statistically significant (P >0.05) to the anxiety 
and behaviour scores of pre-cooperative stage children in this study. 
 
Facial Image Scale to assess anxiety of children before and after sedation (FIS) 
 
The two most commonly used scales to assess anxiety in previous studies examined 
are the Venham Picture Scale (VPS) and the Facial Image Scale (FIS) (Wood, 2011; 
Buchanin and Niven, 2002; Alwin et al, 1991; Newton and Buck, 2000).  The FIS 
was favoured due to its greater validity in a clinical context in comparison to the VPS 
and was thus chosen as the scale for this study (Buchanin and Niven 2002). The FIS 
is easier and quicker to use in a clinical setting (Buchanin and Niven 2002) and was 
found to be useful in young children because they lack the cognitive ability to 
understand straightforward questions about their feelings (Buchanin and Niven, 
2002). The limitations of the scale may still be challenged by the child’s intellectual 
abilities as this varies among children and their age (Buchanin and Niven, 2002). 
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The FIS was applied to this study to ascertain if the state of anxiety of the children 
before sedation had a direct impact on their anxiety and behaviour during dental 
extractions, and whether the children’s mood was affected by the treatment.  
 
The relation of the state of anxiety that is represented by a picture from the FIS is also 
important to ascertain which dose is more effective in decreasing the anxiety. This 
would help clinicians to draw up the optimal treatment plan or decide on the correct 
dosages to manage the different levels of anxiety displayed by children in an 
emergency clinic (Buchanin and Niven, 2002). 
 
Before sedation, 65% of the children selected a happy face (scale of 1 and 2), 
indicating that they were mildly anxious patients and this is consistent with the 
inclusion criteria of the study. The rest of the children (18%) chose a scale of 3 
(neutral face) whereas the children who selected the 4 or 5 scale (sad faces) 
represented 16% of the sample. The sad faces may be due to temperament, 
socioeconomic status or a reflection of parent’s anxiety (Alwin et al, 1991). 
After sedation 61% of children of both doses groups chose a happy face at the end of 
the treatment. This result clearly indicates successful sedation for both the 0.3 and       
0.5 mg/kg doses and further demonstrates the amnesic property of midazolam. 
Interestingly, two parents provided voluntary feedback when they attended the 
emergency clinic for subsequent treatment. The parents reported that their children 
did not remember the dental extractions after treatment on the following day. The 
reports were also supported by the findings that suggested amnesia effect by showing 
that 50% of the children chose the same picture before and after the sedation. 
Moreover the 61% of happy faces after treatment is close to the 65% happy faces 
chosen before commencement of treatment suggesting effective amnesia and 
recovery of children to their usual mood. 
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Furthermore, there was a slight statistical difference in images chosen between the      
0.3 mg/kg and 0.5 mg/kg after sedation with a marginal p-value of 0.059. The                 
0.5 mg/kg group showed a higher percentage (66%) of happy faces in comparison to 
the 55% happy faces chosen in the 0.3 mg/kg group. The 0.5 mg/kg group presented 
with 16% of sad faces chosen in comparison to 22% sad faces in the 0.3 mg/kg group. 
As a result, the 0.5 mg/kg suggests higher anxiolysis and a happier mood in children 
than the 0.3 mg/kg dose.  
In contrast, 20% of the children in the 0.3 mg/kg group selected a neutral face and      
19% a sad face at the end of the treatment. This could be due to the temperament of 
the child, and/or the high anxiety experienced during the treatment. The high anxiety 
could be attributed to factors such as the children’s previous unpleasant experiences 
and their diverse personalities. This is supported by Anrup (2002) who found that shy 
children had higher anxiety levels to the dental treatment in contrast to the children 
that are not shy. 
Moreover, the researcher observed that FIS before and after sedation in children had 
its’ limitations, where the children’s mood or state of anxiety was influenced by the 
parents’ expressions.   
Temperament 
Temperament is defined as “the emotional quality of the child that varies individually 
but is relatively stable over time” (Anrup, 2002). Some children adapt quickly to new 
environments and stimuli while others react with great fear and agitation (Alwin et al, 
1991). Factors such as the temperament and mood of the child also influence how the 
child will react at the time of assessment, determination of the picture scale, and their 
anxiety and behaviour during treatment. Aminabadi et al (2011) concluded that 
temperament is a significant and predictive factor in determining the child’s 
behaviour during treatment. It was shown from the study that some children in the      
0.3 mg/kg and 0.5 mg/kg dose groups had a rating of zero (relaxed and smiling) in the 
anxiety and behaviour scales throughout the treatment.  
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Temperament is believed to possibly have had a positive impact on the anxiety and 
behaviour of these children during the treatment. 
 
Rater’s assessment of anxiety during the different stages of treatment 
The assessment of the effectiveness of the 0.3 mg/kg and 0.5 mg/kg on the anxiety 
and behaviour of children was done using Venham’s scale (Appendix H) throughout 
the procedure of dental extraction (before INS until dental extraction/s).  
 
The before INS results (table 3) showed that children were mildly anxious. However, 
the administration of INS increased the anxiety levels and decreased the cooperation 
of the children (table 7). This increase in anxiety levels was represented by crying 
(table 7) and the cooperation decreased evident by the children protesting with hand 
signals. This could be due to the discomfort of the INS route, which was not well 
tolerated by children. The large volume of the drug due to the low concentration 
(5mg/ml) might have resulted in part of the solution being disseminated in the spray 
and some of the solution leaking into the nasal mucosa causing the nasal burning 
(Wermeling et al, 2006). Also, the low pH of the solution could have stimulated the 
peripheral pain receptors of the trigeminal nerve supply in the nasal mucosa causing 
discomfort (Wood, 2011). 
Local anaesthetic (LA) (lignocaine) was given prior to INS to reduce and or eliminate 
the burning sensation of midazolam. However, 10% of children reported a burning 
sensation, which could be due to the fact that inadequate time was allowed between 
LA administration and the INS administration (Wood, 2011). This implies that 
perhaps a slightly longer time period should be allowed for after the LA in order for it 
to have the maximum anaesthetising effect on the nasal mucosa. 
 
 
	  	  
	  
47	  
According to the findings by Wood (2011), 43% of children had burning sensation in 
his study in comparison to 10% in this study. The lignocaine used in the study by 
Wood (2010) was given with the midazolam as opposed to this study where 
lignocaine was given three to four minutes prior to INS. The effective local 
anaesthesia resulted in an absence of the burning sensation. 
A bitter taste is experienced when the drug is swallowed and this is due to the fact 
that the drug is diluted and a large volume is allowed to pass through the oropharynx 
and makes contact with the tongue (Wood, 2011). The large volume of solution is due 
to the concentration of midazolam being 5mg/ml. The concentrated formulation of            
40 mg/ml used by Wood (2011) had decreased the likelihood of swallowed 
midazolam through the nasopharynx (Wood, 2011). This concentrated dose of 
40mg/ml was believed to result in 57% acceptability during INS in Woods’ study, in 
comparison to 35% acceptability in this study.  
The intranasal sedation studies documented thus far have not included any reports on 
the correct technique of INS using the MAD (Appendix K).The technique could play 
a major role in instances where the child is swallowing the drug leading to bitter taste, 
and also reducing the rapid onset of IN route. It is recommended that the intranasal 
medication be administered with the chin tilted towards the chest to avoid the 
solution from going down the throat and causing a bitter taste. 
The effectiveness of sedation among children varied after INS administration. This 
could be due to the midazolam solution either being swallowed or being expelled 
during sneezing after INS administration. It is thus possible that the bioavailability of 
the drug decreased and therefore different onset times were experienced. It is also 
believed that the quick onset of INS could be due to the passing of the drug through 
the cribriform plate to the brain and cerebrospinal fluid (Lee-Kim et al, 2004). 
Children were continuously assessed until raters reached a consensus that the child 
was drowsy. Drowsiness was confirmed by asking the child to stand up with support. 
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One hundred per cent of the children were drowsy at the interval of 5-10 minutes that 
was also similar to findings made by Rakaf et al (2001) and Wood (2011). This quick 
onset and rapid effectiveness was due to its rapid absorption, bypassing the hepatic 
portal (Lee-kim et al, 2004). The intranasal route of sedation allows for the highest 
bioavailability of the drug compared to the other routes of sedation other than the IV 
route. INS results in quick onset of sedation thus making it the preferred option for its 
use in an emergency setting (Wood, 2011). 
The duration of the treatment between the two groups (figure 15) are in line with 
duration times of Rakaf et al (2001) and Wood (2011), indicating effective sedation 
of the 0.3 mg/kg and 0.5 mg/kg doses which provided sufficient time for emergency 
dental extractions to be carried out. 
Before local anaesthesia was injected, topical anaesthetic was applied whilst the child 
was on the dental chair and the result shows that 85% of children displayed good 
behaviour. This indicates that both the 0.3 mg/kg and 0.5 mg/kg doses provided 
effective sedation. In contrast, when the LA was administered anxiety and behaviour 
levels increased. The children exhibited the highest level of anxiety at this stage by 
being scared (table 7) and their behaviour changed due to the painful sensation of the 
LA. This provoked the children to react by crying (figure 9) and protest by hand 
signals and movement of the head. Pain experienced led to an increase in the ratings 
of anxiety and change in behaviour by more than the scale of 1 in 60% of the 
children. 
After the LA injection was completed, 81% of the children became calm in both dose 
groups. The majority of the children had stopped crying and protesting almost 
immediately after the LA was completed. This rapid calming down response indicates 
effective sedation of both dose groups. 
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The period when the extractions were being performed also produced increase in 
anxiety levels and change in behaviour as demonstrated by the crying and protesting 
(table 7). Nevertheless, patients displayed a lower anxiety level cooperated better than 
during the period when the LA was being administered. This was due to the effective 
analgesia, and more profound level of sedation achieved.  
 
The Stimulation of LA and extraction on Anxiety and behaviour scales 
An emergency clinic usually presents with a large number of patients seeking relief 
from pain and sepsis and there is a need to provide the emergency service quickly and 
effectively. Therefore, to increase the number of patients for treatment in an 
emergency clinic, LA is injected quickly that might aggravate the pain. This increase 
in pain is due to the buffering of the drug. The LA injection should preferably be 
given slowly to provide the desired buffering effect. The anxiety and behaviour of 
children was unstable during the different stages of treatment because midazolam 
lacks analgesic effect. 
The administration of LA resulted in an increased anxiety in children, and showed 
signs of verbal protesting or crying (Mazheri et al, 2007). There are different types of 
LA injections such as the mandibular block, buccal infiltrations and palatal injections 
that presented with different anxiety and behaviour patterns according to the ratings 
used. It was noted that palatal injections caused the highest anxiety and behaviour 
change and had a rating scale of 2. A painful experience such as a local anaesthetic 
injection creates a negative memory associated with fear and psychological trauma 
and this experience exacerbates pain (Salem et al, 2012). 
 
 
 
	  	  
	  
50	  
(E) Safety  
Safety is the primary goal in sedation and the use of a pulse oximeter is compulsory 
to regularly check pulse rate and oxygen saturations as done in this study(Wilson, 
2012). The pulse rates of the children were monitored throughout the procedure and 
charted before and after sedation and both dose groups were in the normal range. The 
mean pulse rate was lower in the 0.5 mg/kg group (108) PR in comparison to 115PR 
in the 0.3 mg/kg. Both mean values of pulse rates of the two groups were within a 
normal range for children aged 3-6 years old (NIH, 2013). However, the 0.5 mg/kg 
suggested more effective anxiolysis.  
The pulse-oximeter also showed oxygen levels above 95% at baseline and after 
treatment indicating adequate breathing and airway patency except one child who 
desaturated briefly. The child who desaturated briefly had an oxygen saturation value 
of 90% for a period of 3 minutes. The child presented with snoring during this brief 
period of desaturation. The initial management in this event of desaturation was by 
stimulating and rousing the child, to increase muscle tone affected by the drug and 
prompt breathing (Wilson, 2012). This manoeuvre normalised the oxygen saturations 
immediately to above 95%. There were no cases that needed respiratory support or 
emergency interventions. Both doses of midazolam had proven to be used safely in 
the emergency clinical setting for the pre-cooperative age group of 3-6 years old 
children. 
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Monitoring and Discharge 
 
Once the dental extractions were completed the child was placed in the recovery 
room for further monitoring and assessment for discharge using the universal 
discharge scale (Appendix J). 
 
According to the universal discharge scale, it is safe to discharge the child when there 
is an accumulative score of 9/12 and the child cannot be discharged if any of the 
parameters being monitored is zero (Appendix J).  Hence, in this study the score was 
further increased to 12/12, which is the optimal discharge score for the reasons of 
safety, consistency and ease of rating.  
 
The majority (90%) of children were discharged after 15 minutes and only 10% of 
children needed to stay in recovery for an additional 15 minutes. The reason for this 
was that they were unable to move all four extremities on command or when the level 
of consciousness was not a score of 2.  
 
The increased recovery time was seen mostly in the 0.5 mg/kg dose group (Figure 
16), which was statistically significant when compared to the 0.3 mg/kg dose group 
(p value=0.03). The greater recovery time seen with the 0.5 mg/kg dose was due to 
the deeper level of sedation achieved with these children. The dosage required for 
INS should take into consideration the child’s behaviour and time required for 
treatment (Rakaf et al 2001).  Rakaf et al (2001) suggested the use of 0.5 mg/kg for 
procedures such as dental extractions. 
The only disadvantage of the 0.5 mg/kg is the slight increase in recovery time, but 
this dose still outweighed the 0.3 mg/kg by producing improved behaviour and 
cooperation during the course of treatment. The FIS scales also illustrated that the 
children presented with an improved state of mind and better mood after treatment 
with the       0.5 mg/kg.  
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The discharge time recorded for the children who had the 0.5 mg/kg dose was seen as 
being statistically significant by a difference of a few minutes in comparison to the 
discharge time recorded for the 0.3 mg/kg dose (figure 16). However, this was not 
viewed as being clinically significant in slowing down the flow of the emergency 
clinic and is thus considered as being the more suitable INS dose in an emergency 
clinic. 
 
Signs and side effects  
Benzodiazepines used for sedation without the combination of opiates or any sedative 
drugs are regarded as minimal sedation, which is less likely to result in adverse 
events due to the wide margin of safety (SAJAA, 2010).  
 
The 0.3 mg/kg and 0.5 mg/kg doses of midazolam in this research have shown no 
significant or serious adverse events such as respiratory depression, apnoea or 
cardiovascular instability. The minor side effects of sneezing might have decreased 
the effectiveness of the dose administered (figure 17). However, this had no 
significant clinical effect on the level of sedation according to the Wilson sedation 
scale or discharge times. Hiccups are a known side effect of midazolam and was 
recorded in two patients and disappeared within seconds after INS.  
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Pre-operative Fasting  
 
Pre-operative fasting cannot be planned for emergency settings; hence sedation that 
does not require for the child to be starved is appropriate for emergency dental 
extractions (Wilson, 2012). 
Due to risk of aspiration, fasting times are mandatory in GA cases rather than 
procedural sedation. The fasting time for procedural sedation is controversial, and the 
gastric emptying is believed to be delayed due to the distracting pain (Wilson, 2012).  
The aim of the study was to achieve minimal but optimal sedation. Therefore, risk of 
aspiration in non-fasting conditions was uneventful in this study, due to the 
maintained protective reflexes of swallowing and normal breathing throughout the 
treatment. Similarly, Rakaf et al (2001) showed that the safety of both 0.3 mg/kg and 
0.5 mg/kg doses in fasting and non-fasting conditions, making INS a suitable sedation 
technique in an emergency setting. 
The oral route of sedation is unpredictable in terms of sedation level and recovery and 
therefore fasting is advised.  In conclusion, fasting for minimal sedation using the    
0.3 mg/kg or 0.5 mg/kg doses intranasally is seen not practical because of immediate 
care needed for emergency dental extractions and considered unnecessary for 
sedation requirements. 
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Limitations 
An adult nasal cavity can only receive and retain 0.15ml of liquid and therefore 
children receiving INS should preferably be administered a concentrated solution in 
order to maximize the effect of the drug and decrease side effects (Wermeling et al, 
2006).  
The use of the diluted dose of 5 mg/ml in the study increased the volume of the drug 
required for sedation therefore increasing the probability of the child experiencing a 
burning sensation in the nasal mucosa and bitter taste in the throat when drug is 
swallowed. The inadequate time given for the Lidocaine to anaesthetize nasal mucosa 
had led to 10% of the children experiencing a burning sensation. The volume of the 
drug and the inadequate time for Lidocaine to anaesthetise the nasal mucosa are the 
reasons that acceptability of INS in this study was decreased. Chiaretti et al (2011) 
used 10 mg/puff lidocaine and results showed that their were no burning sensation 
experienced with the children in their study. 
The technique of administering the IN midazolam where the childs’ head was 
occasionally tilted backwards increased the chance of drug being swallowed, and 
resulted in the bitter taste being experienced and perhaps also decrasing the 
effectiveness of the drug   (Appendix K).  
The inclusion of follow up questionnaires could have been included in the study and 
given to the parents so as to assess any side effects after recovery as well as the 
amnesia expected from the use of midazolam.  
The limited space provided for recovery in a busy emergency clinic affected the 
possibility of having a larger sample size.   
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Chapter (6) 
Conclusion & Recommendations 
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Conclusion 
 
The majority of the anxious children who presented with Early Childhood Caries 
required emergency dental extractions and further comprehensive treatment. Children 
in the pre-cooperative stage are most likely to react to the pain evoked by the LA 
injections due to lack of analgesia in the INM. It is therefore suggested from the 
anxiety and behaviour ratings to add an analgesic agent like ketamine to minimise 
distress, and to reach optimal goals of sedation (Mikhael et al, 2007). It is important 
to consider the risk of over sedation and use the least amount of drugs with the 
highest therapeutic index.  
The administration of LA into the nasal mucosa prior to INS prevented the burning 
sensation from being experienced in 91 percent of the children. Despite the distress in 
the provocative stages of LA and extraction, both doses still succeeded in decreasing 
the anxiety and movement of children.  
 
The 0.5 mg/kg dose resulted in the cooperation and behaviour levels (relaxed and 
smiling throughout the procedure) of this group of children being approximately three 
times better than the group that received the 0.3 mg/kg dose. 
 
The recovery time with the 0.5 mg/kg dose was slightly more than the 0.3 mg/kg, yet 
it did not impede the flow of patients in the emergency clinic.  
INS with 0.3 mg/kg or 0.5 mg/kg midazolam resulted in safe and effective anxiolysis 
for emergency dental treatment in children under the age of six years who did not 
fast. No adverse events related to sedation were encountered throughout the course of 
treatment. 
The 0.5 mg/kg was more effective than the 0.3 mg/kg as it reduced anxiety and 
improved behaviour and thus allowed for these children to be managed more easily. 
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Recommendations 
 
• To avoid distress being experienced during unpleasant procedures such as 
dental extractions, and to adhere to minimal sedation in an emergency clinic, 
additional sedation with nitrous oxide can be utilised together with intranasal 
midazolam. This combination has achieved superior outcomes (P<0.05) in 
terms of movement and crying during LA administration, in comparison to 
midazolam alone as proved by Zahrani et al, (2009). Hence, the intranasal 
midazolam can be used in conjunction with nitrous oxide to improve the 
child’s cooperation and further reduce anxiety. 
 
• The use of a concentrated LA (Lidocaine) (10mg/puff) prior to INS 
administration can be used to reduce or avoid the burning sensation from 
being experienced (Chiaretti et al, 2011).  
 
• A concentrated dose of midazolam such as 25 mg/ml or 40 mg/ml with LA is 
recommended to decrease or avoid burning sensation and bitter taste 
experienced with midazolam. The concentrated dose will also ensure greater 
retention in the nasal cavity thus increases the bioavailability of drug and 
decreases side effects.  
 
• It is also suggested that mint or lemon drops or lemon lozenges could be given 
prior to or after INS This will reduce or eliminate any possibility of bitter taste 
experienced and is advised only to be given to older and mildly anxious 
children to avoid events such as aspiration.  
 
• Operator sedationists in emergency dental clinics can safely and effectively 
use INS in a dose of 0.5 mg/kg for children under the age of six years old 
provided that their vital signs are monitored with a pulse-oximeter, and 
resources that are adequate are available for patient recovery. 
	  	  
	  
58	  
 
• Effective INS with the 0.5 mg/kg is recommended in a hospital setting. The 
availability of experienced staff with PBLS (Paediatric Basic Life Support) 
and PALS (Paediatric Advanced Life Support) qualifications is mandatory as 
stated by the guidelines for the safe use of procedural sedation and analgesia 
for diagnostic and therapeutic procedures in children in order to manage the 
airway and provide medical intervention if required (SAJAA, 2010). 
 
• Intra-nasal flumazenil antagonist is a relieving discovery in an emergency 
setting (Zanette et al, 2009). The intranasal flumazenil have shown similar 
plasma concentrations to the intravenous flumazenil (Scheepers et al, 2000), 
and therefore could be given without intravenous access that is painful for 
children and requires an anaesthetist. The reversal of midazolam by intranasal 
flumazenil can therefore be successfully achieved by the intranasal route and 
can be done by any of the staff members, and not necessarily an anaesthetist. 
 
• Ideally the painful sensation of injections and extraction require an analgesic 
effect in addition to the sedation. Midazolam has an anxiolytic and amnesic 
effect but does not have any analgesic effect. Research on the use of intranasal 
ketamine in the emergency setting is recommended (Wood, 2011) due to its 
analgesic and anxiolytic effect (Mikhael et al, 2007).  
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APPENDIX A:  INFORMATION SHEET 
 
 Please take your time in reading the information sheet; we will do our best to 
explain any part that needs clarity if you have any queries.  
Warm Greetings, 
I would like to kindly request parents/guardians to read this information sheet 
carefully before considering taking part in the study, as this is of great importance to 
us and you, in delivering standard care and the optimal treatment possible to your 
child. To understand the nature of the study to be conducted, this information sheet 
will include details explaining terms such as anxiety that relates to your child and 
sedation being the procedure needed to do the dental extractions required. 
1) Anxiety 
Anxiety is defined as a state in which your child is afraid or stressed to attend the 
dental clinic and especially if an unpleasant procedure is needed, such as dental 
extractions. The condition of your child is normal and is usually expected at this age 
group, as it is difficult for them to understand and adapt to a new and maybe 
threatening environment. It is very much believed that the feeling of pain is more, 
when the child is anxious and afraid. 
2) Definition of Sedation  
“A technique in which the use of  one drug or more produces a state of decreased 
response of the central nervous system, making your child drowsy and enabling 
treatment to be carried out, but during which verbal contact with the patient is 
maintained throughout the period of sedation. The level of sedation must be such that 
the patient remains awake, and is able to react to any stimulation, and to understand 
and to respond to verbal commands”. 
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3) Goals of sedation 
According to South African Journal of Anaesthesia and Analgesia (Sajaa): 
 
The goals of sedation in the paediatric patient for diagnosis and treatment procedures 
are: 
1) To protect the patient's safety and welfare. 
2) To minimize physical discomfort and pain. 
3) To control stress, minimize psychological trauma, and maximize the potential for 
amnesia that means, ability of the drug to make the child forget unpleasant procedure. 
4) To control behaviour and/or movement so as to allow the safe completion of the 
procedure. 
5) To return the patient to a state, in which safe discharge from medical supervision, 
as determined by recognized criteria, is possible. 
 
4)    Name and purpose of the study to be conducted 
The comparison of two doses, of intranasal midazolam sedation, in a Paediatric 
Dental emergency clinic.  
The purpose of the study is to evaluate the doses of midazolam drug to be used in the 
study, meaning to find out which one is the most appropriate in: 
1) Decreasing the stress to your child during dental extraction. 
2) Completion of the procedure without psychological trauma to your child. 
3) To have a reasonable time of recovery that fits the emergency dental clinic, 
and to further accommodate the large number of children that attends the 
emergency dental clinic in Tygerberg Oral Health Centre. 
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This procedure also helps your child to have a pleasant dental experience, because the 
drug is capable of allowing your child, to forget the event of dental extraction. The 
drug used for sedation (midazolam), helps in achieving a good rapport between the 
child and dentist, and not to fear dentistry in the future. 
This study will help us in collecting more information on how your child will react to 
one of these doses. There is a high dose and a lower dose used for the study, your 
child will have an equal chance of either getting a high dose or lower dose for 
treatment. The reason why a high and low doses are suggested in the study, is to 
know which dose would be the best in making your child calm and cooperative, in 
addition to completing dental extraction in a reasonable time to fit the emergency 
dental clinic. These doses have already been proven as effective in previous studies 
taken, and the procedure is already offered in many hospitals. 
The study will help us, to know which dose is better in an emergency setting, and 
aims in treating all children in the event of an emergency effectively (without 
psychological trauma) and quickly. 
5) Why your child is chosen for the study 
Your child and all the children attending the emergency dental clinic are invited to 
take part in the study, if they meet the criteria and for the following reasons: 
1) Within the age group needed for the study (4-6 years of age): as this age group is 
the most anxious, because of difficulty for them to understand why we need to do the 
treatment and difficulty for them to adapt to a new environment. 
2) A healthy child for the study as this will definitely decrease the likelihood of any 
adverse events or complications. 
3) Does not have any airway or nasal abnormalities as this is important to ensure 
safety and effectiveness of the drug. 
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6) Freedom of choice 
The procedure will only be done on your permission and you have the complete right 
to withdraw at any time. In this event your child will still qualify for other options of 
treatment. 
7) Taking part in the study 
The decision to take part in the study will require your child to be medically assessed, 
to ensure safety of your child before procedure. Your child is then going to be 
monitored during and after the procedure, to assess that all the vital signs are normal 
and to intervene if readings are not within the normal limits. 
Your child is given midazolam drug that causes sedation as explained. The drug will 
be given by a mucosal atomized device (MAD). This will give the drug in the form of 
mist through each nostril to achieve sedation, according to the previous studies in an 
average of 15-20 min.  
After your child is calm because of sedation, the child is then given an injection to 
avoid pain and then proceed with the extraction/s required. The child is then taken to 
the recovery room to further assess vital signs and to ensure safety and well-being 
before discharge. The time of the procedure is variable depending on your child’s 
response to the drug and the recovery from the drug.  Our primary goal and intention 
is the safety of the child and secondly, the effectiveness of the drug in terms of 
reduction of stress and fast dental extraction and recovery.   
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8) The cost of the study 
I would like to notify you that the procedure of sedation used in the study, and 
required for your child to undergo dental extraction, is free of cost and is funded by 
the University of the Western Cape. However, if your choice is not to take part in the 
study, other options will be offered and if there are issues regarding cost of treatment, 
you are more than welcome to raise your issue and we will try our best to help in any 
way possible.  
9) Risks of the procedure 
The sedation response is variable and depends from one child to another. The 
possible risks that might occur to your child is to sleep during the procedure, or 
experience breathing difficulty. In the event of any emergency, qualified personnel 
and emergency equipment needed, will always be on site, and the effect of the drug 
can be reversed immediately to return the patient to a fully recovered state. 
10)   Benefits of taking part 
This sedation procedure is stated as safe and effective by numerous studies and 
reports. Compliance in children with intranasal sedation is also much easier and 
acceptable by an anxious child than other routes used. I very much believe that the 
procedure will help in treating your child, by reducing his/her stress and fear from 
dental extraction and allow for good cooperation from your child to complete 
treatment.  
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11)   Confidentiality    
The data to be collected is treated as strictly confidential, and no individually 
identifiable information will be published. The data collected and needed for the 
study, are scores of the level of sedation and recovery time of your child, which is 
going to be added with other results to reach to a conclusion on the effectiveness of 
the two doses used in the study.  
As stated by the American academy of Pediatrics (AAPD):  
 “You, as parent/legal guardian, play a key role in your child's dental care. Children 
often perceive a parent's anxiety which makes them more fearful. They tolerate 
procedures best when their parents understand what to expect and prepare them for 
the experience. If you have any questions about the sedation process, please ask. As 
you become more confident, so will your child” (AAPD, 2011). A telephone/cell 
number will be supplied to you, if you need to contact the dentist. 
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APPENDIX B: CONSENT FORM 
 
Department of Paediatric Dentistry at Tygerberg Oral Health Centre 
To: Dear Parents/guardians of …………………………………………………. 
My name is Dr. Ahmed Mahgoub, I am conducting a research under the supervision 
of the Paediatric Dentistry department and the approval of the University of the 
Western Cape. The research is on the comparison of two doses of intranasal 
midazolam sedation, in the Paediatric Dentistry emergency clinic at Tygerberg Oral 
Health Centre.  
You are being invited to consider taking part in the study, which involves sedation 
through the nostrils that helps to calm your child for dental extraction. The study is 
comparing two doses of midazolam drug and aims to assess which dose is most 
effective in making your child calm, so that he/she is able to cooperate and complete 
dental extraction without stress and psychological trauma, in a reasonable time .The 
purpose of the study is to have an understanding of how your child is going to react to 
the medication, and to investigate which dose is most applicable in an emergency 
setting. 
I would like to inform you that your child after being assessed by our paediatric 
dentists as anxious requires sedation, to perform the extractions required. The drug 
we administer is safe and has been used for a long time. However, it is possible that 
your child might sleep which is a deeper level of sedation. In this event, the drug will 
be immediately be reversed by qualified practitioners to return the patient to a fully 
recovered state. 
In case you still feel uncertain after reading the information sheet provided about the 
nature of the study and the sedation, you can always raise questions, and will try our 
best to clarify any area of concern. It is sometimes challenging to make a decision in 
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situations of an emergency that requires prompt treatment and management, so we 
would kindly request you to take your time reading during your waiting for service, 
to ensure your satisfaction. The procedure will only be done on your permission and 
you have the complete right to withdraw at any time. In this event your child will still 
qualify for other options of treatment. 
I (………………………………………….) have been informed about the study 
entitled (Comparison of two doses of intranasal midazolam sedation in paediatric 
dentistry emergency clinic) by Dr Ahmed Mahgoub. 
I understand the purpose and procedures of the study to assess the level of child being 
calm and determine the recovery time between the two doses of midazolam. 
I have been given an opportunity to ask questions about the study and have had 
answers to my satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may 
withdraw at any time without affecting any treatment or care that I would usually be 
entitled to. 
I have been informed about any available compensation or medical treatment if injury 
occurs to me as a result of study-related procedures. 
If I have any further questions/concerns or queries related to the study I understand 
that I may contact the researcher at Tygerberg Paediatric department. 
If I have any questions or concerns about my rights as a study participant, or if I am 
concerned about an aspect of the study or the researchers then I may contact:  
 
 
DENTISTRY RESEARCH ETHICS COMMMITTEE 
Research Office, Tygerberg Campus 
Fransie van Zyl Drive 
Private Bag X1  
Tygerberg  
7505 
Cape Town, SOUTH AFRICA 
Tel: 27 21 937 3095 - Fax: 27 21 931 2287 
Email: suenaidoo@uwc.ac.za 
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____________________      ____________________ 
Signature of Participant                            Date 
____________________   _____________________ 
Signature of Witness                                Date 
  ____________________             _____________________ 
Signature of Translator                      Date (Where applicable) 
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APPENDIX C: ASA PHYSICAL STATUS CLASSIFICATION 
  
 
ü (Only class I patients are eligible for the study) 
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APPENDIX D: Preparation and Setting up for Sedation Procedures 
 
Part of the safety net of sedation is to use a systematic approach so as to not overlook 
having an important drug, piece of equipment, or monitor immediately available at 
the time of a developing emergency. To avoid this problem, it is helpful to use an 
acronym that allows the same setup and checklist for every procedure. A commonly 
used acronym useful in planning and preparation for a procedure is SOAPME 
(American Academy of Pediatrics and American Academy of Pediatric Dentistry, 
2006). 
S = Size-appropriate suction catheters and a functioning suction apparatus.  
O = an adequate oxygen supply and functioning flow meters/other devices to allow 
its delivery 
A = Airway: size-appropriate airway equipment (nasopharyngeal and oro-pharyngeal 
airways, laryngoscope blades [checked 
and functioning], endotracheal tubes, stylets, face mask, bag-valve-mask or 
equivalent device [functioning]). 
P = Pharmacy: all the basic drugs needed to support life during an emergency, 
including antagonists as indicated. E.g. (Flumazenil needed for reversal effect of 
midazolam). 
M = Monitors: functioning pulse oximeter with size-appropriate oximeter probes and 
other monitors as appropriate for the procedure (e.g., non-invasive blood pressure, 
end tidal, carbon dioxide, ECG, stethoscope). 
E = Special equipment or drugs for a particular ease (e.g., defibrillator 
 
 
 
 
	  	  
	  
76	  
APPENDIX E: CLINICAL PROCEDURE 
 
The study included two operators, the nurse who administers the INS, and one dentist 
performing the dental extractions, and two raters that are needed for intra-rater 
reliability. The nurse who administers the INS will also record the data for 
APPENDIX F.  
The sister who administers the INS will be the only person to know and record the 
dose given to the child. In the event of any adverse reaction the blinding factor will be 
breached if required to ensure safety of the child. 
* Raters are given separate forms to record. 
(A) Before Procedure: 
1. Children to choose anxiety level from the Venham anxiety picture test. 
2. Two raters assessed children for anxiety measurement using Venham’s scale, 
during screening for physical status and medical condition. (Appendix H)  
3. Physical status/airway and general medical condition was assessed using the 
patient selection criteria ASA 1 (Appendix C). 
4. Preparation of sedation (Appendix D). 
5. The dental assistant recorded age and weight of the child and vital signs 
including, pulse rate and oxygen saturation are also recorded at baseline. 
(Appendix F)   
(B) Beginning and during the Procedure: 
6. After explaining the procedure, the first operator administered lignocaine using 
MAD (mucosal atomiser device) to anaesthetize nasal mucosa for 4 min, to 
prevent burning sensation and nasal discomfort caused by intranasal midazolam. 
7. Child would be received treatment via intranasal route using midazolam and 
delivered by a mucosal atomiser devise therefore chances of sneezing and 
significant amount being swallowed is reduced. Any signs of sneezing, 
coughing or swallowing would be recorded by dental assistant. 
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8. A pulse-oximeter was used to monitor and record pulse and oxygen saturation 
prior to treatment, and every 15 min during treatment and at the end of treatment 
in recovery by the dental assistant. 
9. The second operator performed the dental extractions required. 
The nurse recorded: (APPENDIX F) 
a) Time and dose of the drug to be given. 
b) Beginning of procedure 
c) End of procedure. 
10. Level of sedation will be recorded by raters using original Wilson scale. 
(APPENDIX I) 
11. A Qualified medical practitioner was on site in the event of any signs of possible 
deep sedation, and the need for cannulation to reverse effect of midazolam using 
antagonist flumazenil IV. 
 (C) After Procedure 
     10. The patient was taken to the recovery room and further assessed by the raters 
for discharge using the discharge-scoring sheet. (Appendix J)  A score of nine is at 
least needed to discharge the patient. The raters will record the discharge score and 
discharge the patient. 
     11. Post-operative instructions were given to the parents and any signs of        
discomfort should be reported with 24 hours of the procedure. 
     12. A telephone/cell number was given to the parent if they need to contact the 
dentist. 
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APPENDIX F:  RECORDING OF PATIENT DETAILS AND TIME 
BY DENTAL   ASSISTANT 
 
File number………………………… 
Name………………………………..                  
Gender……………………………… 
Age…………………………….. ….                                        
Weight…………………………….. 
Height……………………………… 
Teeth to be extracted………………………   Total number...………………. 
 Dose given is……………………. 
 
Pulse Rate (PR), Oxygen Saturation (OS). 
Time/min Baseline 15min 30min 45min 60min End.of 
Procedure 
Average 
   PR        
   OS        
 
 
Time/min at: 
Drug 
admin./INS 
Before LA In To Recovery Discharge time 
    
 
  
Any signs of coughing, sneezing or swallowing etc…………………… 
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APPENDIX G: Facial Image Scale 
 
 
 
 
 
 
 
Facial Image Scale 
 
Before procedure at waiting room 
 
FIS SCALE NO…………………… 
 
After Recovery  
 
FIS SCALE NO…………………… 
 
 
 
 
 
Patient File number……………………… 
Patient Name………………………………                    
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APPENDIX H: VENHAM SCALE OFANXIETY&BEHAVIOUR 
MEASUREMENT 
  
 
 
Anxiety (A) and behaviour (B) score using Facial image scale. 
0.  Child is relaxed, smiling, willing and able to converse. 
1. Uneasy, concerned. During stressful procedure may protest briefly and quietly to 
indicate discomfort.  Hands remain down or partially raised to signal discomfort. 
Child willing and able to interpret experience as requested. Tense facial expression, 
may have tears in eyes. 
2. Child appears scared. Tone of voice, questions and answers reflect anxiety.  During 
stressful procedure, verbal protest, (quiet) crying, hands tense and raised, (not 
interfering much -- may touch dentist’s hand or instrument, but not pull at it).  Child 
interprets situation with reasonable accuracy and continues to work to cope with 
his/her anxiety. 
3. Shows reluctance to enter situation, difficulty in correctly assessing situational 
threat.  Pronounced verbal protest, crying.  Using hands to try and stop procedure. 
Protest out of proportion to threat.  Child copes with situation with great reluctance 
4. Anxiety interferes with ability to assess situation.  General crying not related to 
treatment. More prominent body movement, child can be reached through verbal 
communication, and eventually with reluctance and great effort he or she begins the 
work of coping with the threat. 
5. Child out of contact with the reality of the threat. General loud crying, unable to 
listen to verbal communication, makes no effort to cope with threat. Actively 
involved, in escape. Physical restraint required. 
Rater Name……………………….. …           
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Behaviour rating scale 
0.  Total cooperation, best possible working conditions, no crying or physical protest. 
1. Mild, soft verbal protest or (quiet) crying as a signal of discomfort, but does not 
obstruct progress. Appropriate behaviour for procedure, i.e., slight start at injection, 
“own" during drilling if hurting, etc. 
2. Protest more prominent. Both crying and hand signals.  May move head around 
making it hard to administer treatment. Protest more distracting and troublesome. 
However, child still complies with request to cooperate. 
3. Protest presents real problem to dentist.  Complies with demands reluctantly, 
requiring extra effort by dentist, body movement. 
4. Protest disrupts procedure, requires that all of the dentist’s attention be directed 
toward the child’s behaviour.  Compliance eventually achieved after considerable 
effort by dentist, but without much actual physical restraint.  (May require holding 
child’s hands or the like to start).More prominent body movement. 
5.  General protest, no compliance or cooperation. Physical restraint is required 
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RATERS RECORDING SHEET 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Anxiety Time 
BEFORE (INS) A:                           
DURING (INS) A:  
BEFORE (LA) A:  
DURING (LA) A:  
BEFORE (XLA) A:  
DURING (XLA) A:  
 Behaviour:                          Time 
BEFORE INS B:  
DURING INS B:  
BEFORE LA B:  
DURING LA B:  
BEFORE XLA B:  
DURING XLA B:  
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APPENDIX I: ORIGINAL WILSON SEDATION SCALE 
 
Rater Name……………………………            
Patient File number……………………… 
Patient Name………………………………..                     
 
 
Sedation level Assessment using above Original Wilson scale. 
 
 
 
 
 
 
 
 
1                  
 
Fully awake and oriented 
2 Drowsy 
 
3 Eyes closed but rousable to command 
stimulation (earlobe tug) 
 
4 Eyes closed but rousable to mild physical 
5 Eyes closed but not rousable to mild 
physical 
From beginning of INS 
to XLA. Time/min  
           Scale 
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APPENDIX J: DISCHARGE SCORING SHEET 
 
As stated and advised by the South African Society of Anaesthesiology, (SAJAA, 
2010) 
Patient file number………………………………. 
 
In to Recovery. After 15 
min 
 Time/min    
           Score 
      
      
  
  
   
Discharge Score: ……………… 
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APPENDIX K: INTRANASAL ADMINISTRATION TECHNIQUE  
 
 
